For Advanced Lung Cancer, Immune Therapy Plus Chemo Prolongs Survival | Latest News RSS feed

For Advanced Lung Cancer, Immune Therapy Plus Chemo Prolongs Survival - Latest News


For advanced lung cancer, immune therapy plus chemo prolongs survival

Patients with newly diagnosed advanced lung cancer who received an immunotherapy drug plus standard chemotherapy lived significantly longer than those who got chemo alone, according to a new study tha... read more

New hope for lung cancer patients Study: Immunotherapy plus chemo prolongs survival

Patients with newly diagnosed advanced lung cancer who received an immunotherapy drug plus ... therapy group who were alive and whose disease had not gotten worse at a year was about 34 percent, about ... read more

First line immunotherapy combination fails to improve overall survival in lung cancer

The combination of immune checkpoint inhibitors and chemotherapy has been successfully tested in different trials as first line therapy ... Nivolumab plus Ipilimumab in Lung Cancer with a High ... read more

Looking for another news?


Immunotherapy Drug Significantly Boosts Odds Of Survival For Lung Cancer Patients

(Loftus and Rockoff, 4/16) The Washington Post: For Advanced Lung Cancer, Immune Therapy Plus Chemo Prolongs Survival Scientists who weren't involved in the study agreed that it was highly significant ... read more


Pembrolizumab Plus Chemo Improved Survival in Advanced NSCLC

The addition of the immune checkpoint inhibitor pembrolizumab to chemotherapy yielded significantly longer overall survival (OS) than chemotherapy alone in patients with newly diagnosed metastatic non... read more

Lung cancer patients live longer with immune therapy

The odds of survival ... the study had an advanced stage of non-squamous non-small-cell lung cancer. The immune-activating drug was a checkpoint inhibitor called pembrolizumab, or Keytruda, made by Me... read more

Immune therapy scores big win against lung cancer in study

For the first time, a treatment that boosts the immune system greatly improved survival ... chemo for the most common form of advanced lung cancer, but doctors have been leery to use it because that w... read more

First Line Immunotherapy Combination Fails to Improve Overall Survival in Lung Cancer: Study

The combination of immune checkpoint inhibitors and chemotherapy has been successfully tested in different trials as first line therapy for metastatic non-small cell lung cancer ... plus tremelimumab, ... read more

Immune therapy scores big win against lung cancer in study

Another study found that an immunotherapy combo – the Bristol-Myers Squibb drugs Opdivo and Yervoy – worked better than chemo for delaying the time until cancer worsened in advanced lung ... survival, ... read more

Researchers extend effectiveness of immunotherapy to more lung cancer patients

Immunotherapy, the strategy for triggering the patient's own immune system to attack cancer ... along with chemotherapy (...) significantly prolongs overall and progression-free survival ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us